Evidence map›Paper›PMID 33475513›Full record

ArticleJournal of medical Internet research2021

Surveillance Metrics of SARS-CoV-2 Transmission in Central Asia: Longitudinal Trend Analysis.

Lori Ann Post, Elana T Benishay, Charles B Moss, Robert Leo Murphy, Chad J Achenbach, Michael G Ison, Danielle Resnick, Lauren Nadya Singh, Janine White, Azraa S Chaudhury and 3 more

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Has Omicron Changed the Evolution of the Pandemic?JMIR public health and surveillance · 2022
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Lori Ann PostBuehler Center for Health Policy and Economics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.ORCID 0000-0002-6261-3254
Elana T BenishayFeinberg School of Medicine, Northwestern University, Chicago, IL, United States.ORCID 0000-0002-5163-3145
Charles B MossInstitute of Food and Agricultural Sciences, University of Florida, Gainsville, FL, United States.ORCID 0000-0002-1172-7112
Robert Leo MurphyInstitute for Global Health, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.ORCID 0000-0003-3936-2052
Chad J AchenbachDivison of Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.ORCID 0000-0003-4847-7249
Michael G IsonDivison of Infectious Disease, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.ORCID 0000-0003-3347-9671
Danielle ResnickInternational Food Policy Research Institute, Washington, DC, United States.ORCID 0000-0001-6285-3461
Lauren Nadya SinghBuehler Center for Health Policy and Economics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.ORCID 0000-0001-7025-9614
Janine WhiteBuehler Center for Health Policy and Economics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.ORCID 0000-0002-7204-477X
Azraa S ChaudhuryFeinberg School of Medicine, Northwestern University, Chicago, IL, United States.ORCID 0000-0002-1977-8205
Michael J BoctorFeinberg School of Medicine, Northwestern University, Chicago, IL, United States.ORCID 0000-0002-9268-8417
Sarah B WelchBuehler Center for Health Policy and Economics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.ORCID 0000-0001-5609-3718
James Francis OehmkeBuehler Center for Health Policy and Economics, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States.ORCID 0000-0003-2003-3443

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSARS-CoV-2, the virus that caused the global COVID-19 pandemic, has severely impacted Central Asia; in spring 2020, high numbers of cases and deaths were reported in this region. The second wave of the COVID-19 pandemic is currently breaching the borders of Central Asia. Public health surveillance is necessary to inform policy and guide leaders; however, existing surveillance explains past transmissions while obscuring shifts in the pandemic, increases in infection rates, and the persistence of the transmission of COVID-19.

objectiveThe goal of this study is to provide enhanced surveillance metrics for SARS-CoV-2 transmission that account for weekly shifts in the pandemic, including speed, acceleration, jerk, and persistence, to better understand the risk of explosive growth in each country and which countries are managing the pandemic successfully.

methodsUsing a longitudinal trend analysis study design, we extracted 60 days of COVID-19-related data from public health registries. We used an empirical difference equation to measure the daily number of cases in the Central Asia region as a function of the prior number of cases, level of testing, and weekly shift variables based on a dynamic panel model that was estimated using the generalized method of moments approach by implementing the Arellano-Bond estimator in R.

resultsCOVID-19 transmission rates were tracked for the weeks of September 30 to October 6 and October 7-13, 2020, in Central Asia. The region averaged 11,730 new cases per day for the first week and 14,514 for the second week. Infection rates increased across the region from 4.74 per 100,000 persons to 5.66. Russia and Turkey had the highest 7-day moving averages in the region, with 9836 and 1469, respectively, for the week of October 6 and 12,501 and 1603, respectively, for the week of October 13. Russia has the fourth highest speed in the region and continues to have positive acceleration, driving the negative trend for the entire region as the largest country by population. Armenia is experiencing explosive growth of COVID-19; its infection rate of 13.73 for the week of October 6 quickly jumped to 25.19, the highest in the region, the following week. The region overall is experiencing increases in its 7-day moving average of new cases, infection, rate, and speed, with continued positive acceleration and no sign of a reversal in sight.

conclusionsThe rapidly evolving COVID-19 pandemic requires novel dynamic surveillance metrics in addition to static metrics to effectively analyze the pandemic trajectory and control spread. Policy makers need to know the magnitude of transmission rates, how quickly they are accelerating, and how previous cases are impacting current caseload due to a lag effect. These metrics applied to Central Asia suggest that the region is trending negatively, primarily due to minimal restrictions in Russia.

Indexed as

Administrative PersonnelArmeniaAsia, CentralAzerbaijanBenchmarkingCOVID-19CyprusDenmarkFood InsecurityGeorgia (Republic)GibraltarHumansKosovoLongitudinal StudiesPandemicsPublic HealthArellano-Bond estimator, generalized method of momentsArmeniaAzerbaijanCentral Asia COVID-19Central Asia COVID-19 surveillance systemCentral Asia COVID-19 transmission speedCentral Asia COVID transmission accelerationCentral Asia econometricsCentral Asia public health surveillanceCentral Asia SARS-CoV-2Central Asia surveillance metricsCOVID-19COVID-19 7-day lagCOVID-19 transmission decelerationCOVID-19 transmission jerkCyprusdynamic panel dataFaeroe Islandsgeneralized method of momentsGeorgiaGibraltarglobal COVID-19 surveillanceGMMinfectious diseaseKazakhstanKosovoKyrgyzstanlongitudinalMacedoniamanagementmonitoringpolicypreventionpublic healthriskRussiaSARS-CoV-2SARS-CoV-2 surveillancesecond wavesurveillanceTajikistan Turkeytransmissiontrendtrend analysisTurkmenistanUzbekistanwave two

Identifiers

PMID33475513
PMCPMC7861038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.